Democratizing gene therapy by reinventing its manufacturing and…
Gene therapy manufacturing is slow, expensive, and requires large specialized facilities and labor, limiting clinical translation and making many rare-disease targets uneconomical.
They build an automated robotic lab and flexible manufacturing system (software + lab automation) to produce gene therapies for clinical trials much faster and cheaper.
Biotech and gene therapy companies and research groups developing gene therapies for human clinical trials.



